欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/H/0503/003
药品名称Betaklav 457 mg/ 5 ml
活性成分
    • amoxicillin 400.0 mg
    • clavulanic acid 62.7 mg
剂型Powder for oral suspension
上市许可持有人KRKA d.d. Novo Mesto Šmarješka cesta 6, 8501 Novo Mesto, Slovenia
参考成员国 - 产品名称Czechia (CZ)
BETAKLAV
互认成员国 - 产品名称
    • Poland (PL)
      Hiconcil comb
    • Latvia (LV)
      Betaklav 400 mg/57 mg/5 ml pulveris iekšķīgi lietojamas suspensijas pagatavošanai
    • Lithuania (LT)
      Betaklav 400 mg / 57 mg/ 5 ml milteliai geriamajai suspensijai
    • Estonia (EE)
      BETAKLAV
    • Hungary (HU)
      BETAKLAV 400 mg/57 mg/5 ml por belsőleges szuszpenzióhoz
    • Bulgaria (BG)
      Betaklav
    • Slovakia (SK)
      Betaklav 400 mg/57 mg/5 ml prášok na perorálnu suspenziu
    • Slovenia (SI)
    • Croatia (HR)
      Betaklav 400 mg/57 mg u 5 ml prašak za oralnu suspenziju
许可日期2015/06/15
最近更新日期2024/03/19
药物ATC编码
    • J01CR02 amoxicillin and beta-lactamase inhibitor
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase